Putting digital into Novartis' DNA is one of new CEO Vas Narasimhan’s goals, and it has just inked another deal that does just that. The drugmaker has teamed with Pear Therapeutics on new software apps in schizophrenia and multiple sclerosis that could eventually be prescribed along with its drugs.Original Article
Digital-minded Novartis strikes deal to create prescription apps that team up with drugs
